John Hancock Classic Value Fund Q4 2025 Commentary

Why It Matters

The fund’s Q4 beat highlights the potency of selective value bets amid a market dominated by AI‑driven momentum, signaling potential upside for investors seeking diversified exposure to resilient consumer and financial firms.

Key Takeaways

• Dollar General drove top quarterly performance
• Fund beat Russell 1000 Value in Q4
• Focus on undervalued firms with durable earnings
• Healthcare lagged, Baxter and Fresenius underperformed

Pulse Analysis

The fourth quarter of 2025 saw U.S. broad market indexes climb, buoyed by investor enthusiasm for artificial‑intelligence themes and the continued strength of momentum‑oriented stocks. In this environment, John Hancock Classic Value Fund managed to outpace its Russell 1000 Value benchmark, underscoring how disciplined value strategies can still capture upside when broader market sentiment leans toward growth. The fund’s performance illustrates that value investors who remain agile can benefit from sector rotations, especially when traditional value pockets intersect with emerging tech narratives.

Sector allocation proved pivotal. Consumer discretionary, financials, and consumer staples powered the fund’s gains, with discount retailer Dollar General and banking giant Citigroup delivering the most material contributions. By increasing exposure to companies facing short‑term headwinds yet possessing durable earnings power, the portfolio leveraged valuation dispersion to secure a performance edge. This approach reflects a broader trend among value managers: seeking hidden upside in businesses that the market temporarily undervalues due to idiosyncratic concerns, rather than shying away from them.

However, the fund’s outlook is not without risk. Healthcare positions, notably Baxter and Fresenius, dragged performance, highlighting the sector’s volatility amid regulatory and pricing pressures. Monitoring these holdings will be essential as earnings cycles evolve. Looking ahead, the fund’s strategy of blending classic value principles with a willingness to embrace nuanced, near‑term challenges positions it to capture long‑term upside while navigating a market still swayed by AI‑centric growth narratives. Investors should weigh the upside of such a hybrid approach against sector‑specific risks, especially in healthcare and other areas showing relative weakness.